Uthaiwan Khongkhanin
nanuthai.bsky.social
Uthaiwan Khongkhanin
@nanuthai.bsky.social
Junior pediatric nephrologist, 🇹🇭
Thank you so much for very informative data. Can I get the full lecture slides (PDF) for further study?
November 11, 2025 at 1:33 PM
Reposted by Uthaiwan Khongkhanin
Problems with our markers of GFR

#NKFClinicals
April 10, 2025 at 6:09 PM
Reposted by Uthaiwan Khongkhanin
Childhood nephrotic syndrome is primarily classified based on its response to corticosteroid treatment. This team will discuss the most current understanding of the pathophysiological mechanisms of MCD:

bit.ly/NM25MCDdx

#NephMadness
#NephMadness 2025: Minimal Change Disease Region
Submit your picks! | @NephMadness | @nephmadness.bsky.social | NephMadness 2025 Selection Committee Member: Susan Samuel @drsusansamuel Susan Samuel is a Clinician Scientist and Pediatric Nephrolog…
bit.ly
March 20, 2025 at 1:59 PM
Reposted by Uthaiwan Khongkhanin
The future of nephrology is here!

We’ve all encountered patients with FSGS and asked:
- Is this primary or secondary?
- When should we consider genetic testing?

This team explores the role of genetics in FSGS, helping us navigate when and how to test:
bit.ly/NM25Genetics...

#NephMadness
#NephMadness 2025: Genetics Region
Submit your picks! | @NephMadness | @nephmadness.bsky.social | NephMadness 2025 Selection Committee Member: Jordan Nestor @thenestor.bsky.social Jordan Nestor, Assistant Professor of Medicine at Co…
bit.ly
March 18, 2025 at 12:51 PM
Reposted by Uthaiwan Khongkhanin
Current treatment guidelines for RAS inhibition is to start for XLAS and ARAS males at the time of diagnosis. This is a point of difference to other glomerular diseases where we start with onset of proteinuria. #IPNA2025
February 19, 2025 at 10:12 AM
Reposted by Uthaiwan Khongkhanin
February 19, 2025 at 7:07 AM
Are there some area of mesangiolysis ?
February 5, 2025 at 3:08 AM